The global increase in obesity has driven the emergence of type 2 diabetes in children.
1,2 Pediatric type 2 diabetes is an aggressive disease with greater risk of end-organ damage and comorbidities than pediatric type 1 diabetes or adult-onset type 2 diabetes.
1-5 The kidneys are notable early targets of type 2 diabetes–associated organ damage, and diabetes-related nephropathy commonly manifests as hypertension and albuminuria.
6-8 If untreated, hypertension is associated with cardiovascular anomalies, including increased carotid intima-media thickness and left ventricular hypertrophy.
9,10 These subclinical adverse outcomes are known risk factors for future cardiovascular disease and mortality.
9,10 Similarly, microalbuminuria is the first sign of diabetes-related nephropathy and can progress to chronic kidney disease and end-stage kidney disease if untreated.
11